For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
The current state of pharmaceutical tariffs
Background Amid the Trump trade upheaval, pharmaceutical products receive different treatment than many other US imports. Pharmaceuticals are treated differently for reasons such as their…
DC Journal
Point: Medicaid Work Requirements Are a Common-Sense Reform
Medicaid is the government program that is supposed to help the poor afford health care. Its cost to taxpayers has skyrocketed in the last few…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Search Posts
Comment
The Precautionary Principle: Protectionism and Environmental Extremism by Other Means
The Precautionary Principle: Protectionism and Environmental Extremism by Other Means …
Op-Eds
Want to Avoid GM Foods? This Regulation Won’t Help
Yesterday, the European Parliament’s Environment Committee voted to expand the EU’s labelling requirement for Genetically Modified foods. The measure, in the form of…
Op-Eds
Worrying About Frankenstein’s Monster
A specter is haunting Europe—called the “precautionary principle”. As generally defined, the precautionary principle states that a product or technology can be banned even if…
Citation
Cancer Doctors on the FDA
Op-Eds
Battling Hunger With Biotechnology
Needless restrictions on agricultural biotechnology would harm the world's ability to battle hunger in the 21st century, say Gregory Conko and C.S. Prakash, co-founders…
News Release
FDA Too Slow to Approve New Medical Drugs and Devices
A new nationwide poll of cancer specialists sponsored by the Competitive Enterprise Institute finds many of them believe the FDA is too slow in approving…
